Ha habido 50 transacciones internas recientes registradas para Compass Therapeutics, Inc. (CMPX), incluyendo 35 compras y 11 ventas. El total de compras internas fue valorado en $40.34M y el total de ventas internas en $12.64M.
Internos destacados con actividad reciente incluyen Schuetz Thomas J., Lindahl Richard S, Gray Mary Ann. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CMPX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-08 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
36,687 |
$6.52 |
$239.2K |
6,603,336 |
| 2026-01-09 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
46,777 |
$5.35 |
$250.26K |
6,640,023 |
| 2026-01-02 |
Lindahl Richard S |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Gray Mary Ann |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Gordon Carl L |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Chiniara Ellen |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Lerner Neil |
Chief Accounting Officer |
Concesión de RSU |
62,500 |
$5.17 |
$323.13K |
382,500 |
| 2026-01-02 |
Schuetz Thomas J. |
CEO |
Concesión de RSU |
2,000,000 |
$5.17 |
$10.34M |
2,000,000 |
| 2026-01-02 |
Shin Barry |
CFO |
Concesión de RSU |
125,000 |
$5.17 |
$646.25K |
525,000 |
| 2026-01-02 |
Sirard Cynthia |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-01-02 |
Sirard Cynthia |
Chief Medical Officer |
Concesión de RSU |
1,000,000 |
$5.17 |
$5.17M |
1,000,000 |
| 2026-01-02 |
Ferneau Philip |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Boylan James P |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Anderman Jonathan |
General Counsel |
Concesión de RSU |
150,000 |
$5.17 |
$775.5K |
171,000 |
| 2026-01-02 |
Prasad Arjun |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-01-02 |
Prasad Arjun |
Chief Commercial Officer |
Concesión de RSU |
1,000,000 |
$5.17 |
$5.17M |
1,000,000 |
| 2025-11-16 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
44,025 |
$4.83 |
$212.64K |
6,436,800 |
| 2025-05-27 |
Schuetz Thomas J. |
Chief Executive Officer |
Compra Informativa |
10,000 |
$2.11 |
$21.1K |
6,480,825 |
| 2025-04-09 |
Orbimed Advisors Llc |
10 Percent Owner |
Venta Informativa |
3,571,428 |
$1.59 |
$5.68M |
- |
| 2025-04-09 |
Gordon Carl L |
10 Percent Owner |
Venta Informativa |
3,571,428 |
$1.59 |
$5.68M |
- |
| 2025-04-07 |
Lerner Neil |
Chief Accounting Officer |
Compra Informativa |
20,000 |
$1.42 |
$28.4K |
320,000 |
| 2025-04-07 |
Anderman Jonathan |
Gen Counsel & Corporate Sec |
Compra Informativa |
20,000 |
$1.54 |
$30.8K |
21,000 |
| 2025-02-11 |
Lindahl Richard S |
Director |
Concesión de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Gray Mary Ann |
Director |
Concesión de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Gordon Carl L |
10 Percent Owner |
Concesión de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Chiniara Ellen |
Director |
Concesión de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Lerner Neil |
SVP, CAO |
Concesión de RSU |
200,000 |
$3.65 |
$730K |
200,000 |
| 2025-02-11 |
Schuetz Thomas J. |
Chief Executive Officer |
Concesión de RSU |
1,500,000 |
$3.65 |
$5.48M |
1,500,000 |
| 2025-02-11 |
Shin Barry |
CFO |
Concesión de RSU |
250,000 |
$3.65 |
$912.5K |
250,000 |
| 2025-02-11 |
Ferneau Philip |
Director |
Concesión de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Boylan James P |
Director |
Concesión de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
Concesión de RSU |
280,000 |
$3.65 |
$1.02M |
280,000 |
| 2025-02-08 |
Schuetz Thomas J. |
CEO |
Retención Fiscal de RSU |
41,687 |
$3.50 |
$145.9K |
6,470,825 |
| 2025-01-09 |
Schuetz Thomas J. |
CEO |
Retención Fiscal de RSU |
58,054 |
$1.86 |
$107.98K |
6,512,512 |
| 2024-12-09 |
Lerner Neil |
VP Finance |
Desconocido |
175,000 |
$1.20 |
$210K |
- |
| 2024-12-09 |
Shin Barry |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-12-09 |
Shin Barry |
CFO |
Concesión de RSU |
400,000 |
$1.65 |
$660K |
400,000 |
| 2024-08-13 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
Concesión de RSU |
300,000 |
$1.20 |
$360K |
300,000 |
| 2024-08-01 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
Disposición |
80,000 |
$1.57 |
$125.6K |
- |
| 2024-03-08 |
Boylan James P |
Director |
Concesión de RSU |
40,000 |
$1.96 |
$78.4K |
40,000 |
| 2024-02-09 |
Lindahl Richard S |
Director |
Concesión de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Gray Mary Ann |
Director |
Concesión de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Gordon Carl L |
10 Percent Owner |
Concesión de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Chiniara Ellen |
Director |
Concesión de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Ferneau Philip |
Director |
Concesión de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-08 |
Schuetz Thomas J. |
President |
Retención Fiscal de RSU |
44,782 |
$1.45 |
$64.93K |
6,570,566 |
| 2024-02-08 |
Bisker-leib Vered |
Chief Executive Officer |
Retención Fiscal de RSU |
49,198 |
$1.45 |
$71.34K |
3,124,426 |
| 2024-01-09 |
Schuetz Thomas J. |
President of R&d |
Concesión de RSU |
637,500 |
$1.93 |
$1.23M |
637,500 |
| 2024-01-09 |
Bisker-leib Vered |
Chief Executive Officer |
Concesión de RSU |
1,753,125 |
$1.93 |
$3.38M |
1,753,125 |
| 2023-11-17 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
44,025 |
$1.50 |
$66.04K |
5,977,848 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
